LOW-DOSE LENALIDOMIDE IN ADDITION TO LOW-DOSE CYTARABINE INDUCES LONG-LASTING COMPLETE REMISSIONS IN A SUBSTANTIAL PROPORTION OF VERY ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS WITH UNFAVORABLE KARYOTYPE

被引：0
|
作者：
Visani, G. [1 ]
Ferrara, F. [2 ]
Di Raimondo, F. [3 ]
Caraci, M. [3 ]
Izzo, T. [2 ]
Riccardi, C. [2 ]
Barulli, S. [1 ]
Guiducci, B. [1 ]
Loscocco, F. [1 ]
Ricciardi, T. [1 ]
Sparaventi, G. [1 ]
Isidori, A. [1 ]
机构：
[1] Hematol & Stem Cell Transplant Ctr, Pesaro, Italy
[2] Cardarelli Hosp, Hematol, Naples, Italy
[3] Catania Univ, Hematol, Catania, Italy
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0057
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [21] A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia
    Schliemann, Christoph
    Gerss, Joachim
    Wiebe, Stefanie
    Mikesch, Jan-Henrik
    Knoblauch, Nicola
    Sauer, Tim
    Angenendt, Linus
    Kewitz, Tobias
    Urban, Marc
    Butterfass-Bahloul, Trude
    Edemir, Sabine
    Vehring, Kerstin
    Mueller-Tidow, Carsten
    Berdel, Wolfgang E.
    Krug, Utz
    PLOS ONE, 2016, 11 (10):
  • [22] Arsenic Trioxide and Low-dose Cytarabine in Older Patients With Untreated Acute Myeloid Leukemia, Excluding Acute Promyelocytic Leukemia
    Roboz, Gail J.
    Ritchie, Ellen K.
    Curcio, Tania
    Provenzano, Juliette
    Carlin, Rebecca
    Samuel, Michael
    Wittenberg, Beth
    Mazumdar, Madhu
    Christos, Paul J.
    Mathew, Susan
    Allen-Bard, Sandra
    Feldman, Eric J.
    CANCER, 2008, 113 (09) : 2504 - 2511
  • [23] LOW-DOSE CYTARABINE VERSUS INTENSIVE CHEMOTHERAPY IN THE TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA IN THE ELDERLY
    TILLY, H
    CASTAIGNE, S
    BORDESSOULE, D
    CASASSUS, P
    LEPRISE, PY
    TERTIAN, G
    DESABLENS, B
    HENRYAMAR, M
    DEGOS, L
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) : 272 - 279
  • [24] Durable clinical and cytogenetic remission in an elderly patient with relapsed acute myeloid leukemia treated with low-dose lenalidomide
    Basile, Frank G.
    LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 653 - 655
  • [25] Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience
    Bashir, Yasir
    Geelani, Sajjad
    Bashir, Nusrat
    Mir, Shabeer A.
    Mushtaq, Mosin
    Jan, M. Aleem
    Rasool, Javid
    SOUTH ASIAN JOURNAL OF CANCER, 2015, 4 (01) : 4 - 6
  • [26] Low-dose melphalan in elderly acute myeloid leukaemia: complete remissions but resistant relapse with therapy-related karyotypes
    R Kerr
    J Cunningham
    DT Bowen
    Leukemia, 2000, 14 : 953 - 953
  • [27] Low-dose melphalan in elderly acute myeloid leukaemia: complete remissions but resistant relapse with therapy-related karyotypes
    Kerr, R
    Cunningham, J
    Bowen, DT
    LEUKEMIA, 2000, 14 (05) : 953 - 953
  • [28] A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
    Berdel, Andrew F.
    Koch, Raphael
    Gerss, Joachim
    Hentrich, Marcus
    Peceny, Rudolf
    Bartscht, Tobias
    Steffen, Bjoern
    Bischoff, Marina
    Spiekermann, Karsten
    Angenendt, Linus
    Mikesch, Jan-Henrik
    Kewitz, Tobias
    Butterfass-Bahloul, Trude
    Serve, Hubert
    Lenz, Georg
    Berdel, Wolfgang E.
    Krug, Utz
    Schliemann, Christoph
    ANNALS OF HEMATOLOGY, 2023, 102 (01) : 63 - 72
  • [29] Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia
    Martinez-Cuadron, David
    Montesinos, Pau
    Oriol, Albert
    Salamero, Olga
    Vidriales, Belen
    Bergua, Juan
    Herrera, Pilar
    Vives, Susanna
    Sanz, Jaime
    Carpio, Cecilia
    Rodriguez-Veiga, Rebeca
    Moscardo, Federico
    Sanz, Miguel A.
    ANNALS OF HEMATOLOGY, 2014, 93 (01) : 43 - 46
  • [30] Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia
    David Martínez-Cuadrón
    Pau Montesinos
    Albert Oriol
    Olga Salamero
    Belén Vidriales
    Juan Bergua
    Pilar Herrera
    Susanna Vives
    Jaime Sanz
    Cecilia Carpio
    Rebeca Rodríguez-Veiga
    Federico Moscardó
    Miguel A. Sanz
    Annals of Hematology, 2014, 93 : 43 - 46
12345